bc-ontologyGovernments, institutions, geography and law
Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

21 CFR 310.306 Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applications.

21 CFR 310.306 Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applications., “Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for…”, is a CFR section of 21 CFR Part 310, Subpart D—Records and Reports; in force.

https://ontology.bommaritollc.com/id/01a0f094-c475-70cd-a13a-5fc6c8b9272d
schema:Legislation
Download TurtleJSON-LDN-TriplesMarkdown
Cite this
21 CFR 310.306 Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applications.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c475-70cd-a13a-5fc6c8b9272d

Elsewhere

Facts

adms:identifier
eli:cites
prov:wasDerivedFrom
schema:isPartOf
schema:legislationIdentifier
21 CFR 310.306
schema:legislationJurisdiction
schema:legislationLegalForce
schema:legislationType
schema:name
Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applicationsen
schema:url
skos:prefLabel
21 CFR 310.306 Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applications.en

Related

Cited by (1)eli:cites